Nucleotech LLC
This article was originally published in Start Up
Executive Summary
Cell therapy start-up Nucleotech LLC is developing an in vitro method for reprogramming mature cells, transdifferentiating them into other kinds of mature cells for autologous therapeutic use against diabetes, cancer, cardiac disease and a host of other indications.